Haleon plc: Notice of Annual General Meeting (AGM)
4 April 2025: Haleon plc (the "Company" or "Haleon") today announces that the following documents have been made available to shareholders:
1. Notice of 2025 Annual General Meeting (the "Notice");
2. Form of Proxy for 2025 Annual General Meeting; and
3. AGM Voting Instruction Card.
Haleon's AGM will again be a virtual meeting, broadcast under studio conditions from the Company's London offices at 3.00pm (BST) on Wednesday 28 May 2025. The Notice is available on the Company's website at https://www.haleon.com/investors/shareholder-information/annual-general-meetings, and includes full details of the business to be conducted and joining instructions.
In compliance with UK Listing Rule 6.4.1R, a copy of the above documents has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Amanda Mellor
Company Secretary
Enquiries
Investors | Media | ||
Jo Russell | +44 7787 392441 | Zoë Bird | +44 7736 746167 |
Rakesh Patel | +44 7552 484646 | Victoria Durman | +44 7894 505730 |
Emma White | +44 7823 523562 | ||
Email: [email protected] | Email: [email protected] | ||
About Haleon
Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.
For more information, please visit www.haleon.com.